{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:28:50Z","timestamp":1794580130421,"version":"4.9.1"},"reference-count":15,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T00:00:00Z","timestamp":1274832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Interleukin\u20102 (IL\u20102) is one of the most studied cytokines driving T\u2010cell proliferation, activation and survival. It binds to the IL\u20102 receptor consisting of three chains, the \u03b1 (CD25), \u03b2 and common \u03b3 (\u03b3c). The binding of the CD25 chain to IL\u20102 is necessary to expose high\u2010affinity binding sites for the \u03b2 and \u03b3c chains, which, in turn, are responsible for downstream signalling. A high level of soluble CD25 (sCD25) has been associated with a poor prognosis in patients with non\u2010Hodgkin\u2019s lymphoma. The function and source of origin of this soluble receptor is not well investigated. In the present study we hypothesized that T regulatory (Treg) cells may release CD25 to act as a decoy receptor for IL\u20102, thereby depriving T\u2010effector cells of IL\u20102. Peripheral blood from patients with B\u2010cell malignancies (<jats:italic>n<\/jats:italic>\u2003=\u200326) and healthy controls (<jats:italic>n<\/jats:italic>\u2003=\u200327) was investigated for the presence and function of FoxP3<jats:sup>+<\/jats:sup> Treg cells and sCD25 by multi\u2010colour flow cytometry and enzyme\u2010linked immunosorbent assay. Further, the proliferative capacity of T cells was evaluated with or without the presence of recombinant sCD25. The results demonstrate that Treg cells from patients had lower CD25 expression intensity and that they released CD25 <jats:italic>in vitro<\/jats:italic>. Further, high levels of Treg cells correlated with sCD25 plasma concentration. Recombinant sCD25 could suppress T\u2010cell proliferation <jats:italic>in vitro<\/jats:italic>. In conclusion, the release of sCD25 by Treg cells may be a mechanism to deprive IL\u20102 and thereby inhibit anti\u2010tumour T\u2010cell responses.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2010.03308.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T04:13:07Z","timestamp":1274933587000},"page":"371-376","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["T regulatory cells control T\u2010cell proliferation partly by the release of soluble CD25 in patients with B\u2010cell malignancies"],"prefix":"10.1111","volume":"131","author":[{"given":"Camilla A.","family":"Lindqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"Christiansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Olsson\u2010Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica S. I.","family":"Loskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,26]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.02.011"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.2741\/1631"},{"key":"e_1_2_7_4_2","first-page":"752","article-title":"Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non\u2010Hodgkin\u2019s lymphoma","volume":"83","author":"Perez\u2010Encinas M","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500361029"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0600-9"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1155\/S0962935193000018"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V72.2.447.bloodjournal722447","article-title":"The malignant B cells from B\u2010chronic lymphocytic leukemia patients release TAC\u2010soluble interleukin\u20102 receptors","volume":"72","author":"Kay NE","year":"1988","journal-title":"Blood"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2009.02268.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.11.006"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0704bs72"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2006.10.008"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.2741\/2773"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1536"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3804"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2010.03308.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2010.03308.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:45:35Z","timestamp":1697363135000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2010.03308.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,26]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1365-2567.2010.03308.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03308.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,26]]},"assertion":[{"value":"2010-05-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}